[4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidin-1-yl]-[3-(trifluoromethyl)phenyl]methanone;5-bromo-6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;3-bromo-N-cyclohexyl-6-phenylimidazo[1,2-a]pyrazin-8-amine;3-chloro-6-(2-chlorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;ethyl 4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidine-1-carboxylate;3-iodo-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine
C135H112Br4Cl6F3I3N34O3 — CID 157429537
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidin-1-yl]-[3-(trifluoromethyl)phenyl]methanone;5-bromo-6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;3-bromo-N-cyclohexyl-6-phenylimidazo[1,2-a]pyrazin-8-amine;3-chloro-6-(2-chlorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;ethyl 4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidine-1-carboxylate;3-iodo-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine
[4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidin-1-yl]-[3-(trifluoromethyl)phenyl]methanone;5-bromo-6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;3-bromo-N-cyclohexyl-6-phenylimidazo[1,2-a]pyrazin-8-amine;3-chloro-6-(2-chlorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;ethyl 4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidine-1-carboxylate;3-iodo-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine (PubChem CID 157429537) has the molecular formula C135H112Br4Cl6F3I3N34O3 and a molecular weight of 3228.66 g/mol. Its IUPAC name is [4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidin-1-yl]-[3-(trifluoromethyl)phenyl]methanone;5-bromo-6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;3-bromo-N-cyclohexyl-6-phenylimidazo[1,2-a]pyrazin-8-amine;3-chloro-6-(2-chlorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;ethyl 4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidine-1-carboxylate;3-iodo-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine.
Molecular Properties
| Compound Name | [4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidin-1-yl]-[3-(trifluoromethyl)phenyl]methanone;5-bromo-6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;3-bromo-N-cyclohexyl-6-phenylimidazo[1,2-a]pyrazin-8-amine;3-chloro-6-(2-chlorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;ethyl 4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidine-1-carboxylate;3-iodo-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine |
|---|---|
| PubChem CID | 157429537 |
| Molecular Formula | C135H112Br4Cl6F3I3N34O3 |
| Molecular Weight | 3228.66 g/mol |
| Exact Mass | 3220.16 |
| IUPAC Name | [4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidin-1-yl]-[3-(trifluoromethyl)phenyl]methanone;5-bromo-6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;3-bromo-N-cyclohexyl-6-phenylimidazo[1,2-a]pyrazin-8-amine;3-chloro-6-(2-chlorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;6-(2-chlorophenyl)-3-iodo-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine;ethyl 4-[[3-bromo-6-(2-chlorophenyl)imidazo[1,2-a]pyrazin-8-yl]amino]piperidine-1-carboxylate;3-iodo-6-phenyl-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine |
| SMILES | Brc1cnc2c(NC3CCCCC3)nc(-c3ccccc3)cn12.CCOC(=O)N1CCC(Nc2nc(-c3ccccc3Cl)cn3c(Br)cnc23)CC1.Clc1ccccc1-c1cn2c(Cl)cnc2c(NCc2cccnc2)n1.Clc1ccccc1-c1cn2c(I)cnc2c(NCc2cccnc2)n1.Clc1ccccc1-c1nc(NCc2cccnc2)c2ncc(I)n2c1Br.Ic1cnc2c(NCc3cccnc3)nc(-c3ccccc3)cn12.O=C(c1cccc(C(F)(F)F)c1)N1CCC(Nc2nc(-c3ccccc3Cl)cn3c(Br)cnc23)CC1 |
| InChI | InChI=1S/C25H20BrClF3N5O.C20H21BrClN5O2.C18H12BrClIN5.C18H19BrN4.C18H13Cl2N5.C18H13ClIN5.C18H14IN5/c26-21-13-31-23-22(33-20(14-35(21)23)18-6-1-2-7-19(18)27)32-17-8-10-34(11-9-17)24(36)15-4-3-5-16(12-15)25(28,29)30;1-2-29-20(28)26-9-7-13(8-10-26)24-18-19-23-11-17(21)27(19)12-16(25-18)14-5-3-4-6-15(14)22;19-16-15(12-5-1-2-6-13(12)20)25-17(18-24-10-14(21)26(16)18)23-9-11-4-3-7-22-8-11;19-16-11-20-18-17(21-14-9-5-2-6-10-14)22-15(12-23(16)18)13-7-3-1-4-8-13;2*19-14-6-2-1-5-13(14)15-11-25-16(20)10-23-18(25)17(24-15)22-9-12-4-3-7-21-8-12;19-16-11-22-18-17(21-10-13-5-4-8-20-9-13)23-15(12-24(16)18)14-6-2-1-3-7-14/h1-7,12-14,17H,8-11H2,(H,32,33);3-6,11-13H,2,7-10H2,1H3,(H,24,25);1-8,10H,9H2,(H,23,25);1,3-4,7-8,11-12,14H,2,5-6,9-10H2,(H,21,22);2*1-8,10-11H,9H2,(H,22,24);1-9,11-12H,10H2,(H,21,23) |
| InChIKey | BQJDNVNOEOBFEM-UHFFFAOYSA-N |
| XLogP | 35.10 |
| TPSA | 396.95 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 188 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3228.66 |
| LogP ≤ 5 | 35.10 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 35 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157429537 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.